Topical Immunotherapy Reduces Squamous Cell Carcinoma Risk Topical Immunotherapy Reduces Squamous Cell Carcinoma Risk
A common chemotherapy combined with a synthetic vitamin D analog eliminated actinic keratosis and decreased skin cancer risk for 3 years.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Hematology | Immunotherapy | Skin | Skin Cancer | Squamous Cell Carcinoma | Vitamin D | Vitamins